Biomarkers of the rapid clinical response to ketamine in treatment-resistant depression: focus on kynurenine

被引：0
|
作者：
Clarke, G. [1 ,2 ]
Naughton, M. [1 ]
O'Shea, R. [3 ]
Dowling, J. [4 ]
Walsh, A. [4 ]
Ismail, F. [1 ]
Shorten, G. [4 ]
Scott, L. [1 ]
Cryan, J. F. [2 ,5 ]
Dinan, T. G. [1 ,2 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Sch Med, Cork, Ireland
[4] Natl Univ Ireland Univ Coll Cork, Dept Anaesthesia & Intens Care Med, Cork, Ireland
[5] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70736-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.015
引用
收藏
页码：S460 / S460
页数：1
相关论文
共 50 条
  • [11] Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression
    Park, Minkyung
    Newman, Laura E.
    Gold, Philip W.
    Luckenbaugh, David A.
    Yuan, Peixiong
    Machado-Vieira, Rodrigo
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 84 : 113 - 118
  • [12] Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
    Cornwell, Brian R.
    Salvadore, Giacomo
    Furey, Maura
    Marquardt, Craig A.
    Brutsche, Nancy E.
    Grillon, Christian
    Zarate, Carlos A., Jr.
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 72 (07) : 555 - 561
  • [13] RAPID RESPONSE TO LITHIUM IN TREATMENT-RESISTANT DEPRESSION
    JOYCE, PR
    HEWLAND, HR
    JONES, AV
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1983, 142 (FEB) : 204 - 206
  • [14] Magnetoencephalography biomarkers of suicide attempt history and antidepressant response to ketamine in treatment-resistant major depression
    Gilbert, Jessica R.
    Gerner, Jessica L.
    Burton, Courtney R.
    Nugent, Allison C.
    Zarate, Carlos A., Jr.
    Ballard, Elizabeth D.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2022, 312 : 188 - 197
  • [15] Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study
    Kang, Melody J. Y.
    Vazquez, Gustavo H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2022, 318 : 331 - 337
  • [16] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [17] Oral ketamine for treatment-resistant depression
    Kang, Seema
    [J]. LANCET PSYCHIATRY, 2018, 5 (11): : 877 - 877
  • [18] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    [J]. BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [19] KETAMINE FOR ADOLESCENT TREATMENT-RESISTANT DEPRESSION
    Cullen, Kathryn R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S345 - S345
  • [20] SUBLINGUAL KETAMINE FOR TREATMENT-RESISTANT DEPRESSION
    Hyde, S.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 154 - 154
12345